Webster Bank, N. A. Gilead Sciences, Inc. Transaction History

Webster Bank, N. A.

$922 Million
Q4 2024

A detailed history of Webster Bank, N. A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Webster Bank, N. A. holds 1,051 shares of GILD stock, worth $97,658. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,051

Previous 1,051 -0.0%

Holding current value

$97,658

Previous $88,000 10.23%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$77.31 - $88.08 $8,736 - $9,953	113 Added 12.05%	1,051 $87,000
Q4 2022 Jan 18, 2023	SELL	$62.32 - $89.47 $12,464 - $17,894	-200 Reduced 17.57%	938 $81,000
Q2 2022 Jul 12, 2022	SELL	$57.72 - $65.01 $2,886 - $3,250	-50 Reduced 4.21%	1,138 $71,000
Q4 2021 Jan 12, 2022	BUY	$64.88 - $73.64 $37,630 - $42,711	580 Added 95.39%	1,188 $86,000
Q3 2021 Oct 12, 2021	SELL	$67.69 - $73.03 $10,153 - $10,954	-150 Reduced 19.79%	608 $43,000
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $6,263 - $8,022	-100 Reduced 11.66%	758 $57,000
Q4 2019 Jan 14, 2020	SELL	$61.62 - $67.78 $27,729 - $30,501	-450 Reduced 34.4%	858 $56,000
Q2 2019 Jul 11, 2019	BUY	$61.87 - $69.38 $18,561 - $20,814	300 Added 29.76%	1,308 $88,000
Q1 2019 Apr 10, 2019	SELL	$62.53 - $70.05 $13,131 - $14,710	-210 Reduced 17.24%	1,008 $65,000
Q2 2018 Jul 12, 2018	SELL	$64.88 - $75.68 $21,734 - $25,352	-335 Reduced 21.57%	1,218 $87,000
Q1 2018 Apr 19, 2018	SELL	$72.84 - $88.8 $100,155 - $122,100	-1,375 Reduced 46.96%	1,553 $117,000
Q4 2017 Jan 23, 2018	BUY	$71.15 - $83.52 $108,503 - $127,368	1,525 Added 108.7%	2,928 $210,000
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $101,170 - $119,914	1,403	1,403 $113,000

Others Institutions Holding GILD

# of Institutions

1,939

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Webster Bank, N. A., based on Form 13F filings with the SEC.

News

Stay updated on Webster Bank, N. A. with notifications on news.

Account